BiotechTube
Home/Anokion/John H. B. Johnson
JH

John H. B. Johnson

Chief Scientific Officer

Anokion

Therapeutic Areas

Autoimmune DiseasesCeliac DiseaseMultiple Sclerosis

Anokion Pipeline

DrugIndicationPhase
ANK-700Celiac DiseasePhase 1b/2
ANK-800Multiple SclerosisPhase 1

Leadership Team at Anokion

DG
Deborah Geraghty
Chief Executive Officer
MB
Matthew B. Frankel
Chief Medical Officer
View full Anokion profile